Abnormal results on screening tests may mean a patient has prostate cancer, but these tests alone can’t diagnose prostate cancer. A prostate biopsy is needed for a definitive diagnosis. Edward M. Schaeffer, MD, PhD, shares the latest prostate biopsy techniques. He discusses transrectal ultrasound-guided (TRUS) biopsy and the ways that Northwestern Medicine is working to optimize cancer detection and ensure patient safety.
